APA (7th ed.) Citation

Brighton, T., Khot, A., Harrison, S. J., Ghez, D., Weiss, B. M., Kirsch, A., . . . Goldschmidt, H. (2019). Randomized, double-blind, placebo-controlled, multicenter study of siltuximab in high-risk smoldering multiple myeloma. Clinical cancer research, 25(13), . https://doi.org/10.1158/1078-0432.CCR-18-3470

Chicago Style (17th ed.) Citation

Brighton, Timothy, et al. "Randomized, Double-blind, Placebo-controlled, Multicenter Study of Siltuximab in High-risk Smoldering Multiple Myeloma." Clinical Cancer Research 25, no. 13 (2019). https://doi.org/10.1158/1078-0432.CCR-18-3470.

MLA (9th ed.) Citation

Brighton, Timothy, et al. "Randomized, Double-blind, Placebo-controlled, Multicenter Study of Siltuximab in High-risk Smoldering Multiple Myeloma." Clinical Cancer Research, vol. 25, no. 13, 2019, https://doi.org/10.1158/1078-0432.CCR-18-3470.